Download
https://medicaldialogues.in/news/industry/pharma/revise-phase-iii-ct-protocol-of-cholera-vaccine-to-add-safety-cdsco-panel-tells-bharath-biotech-105414
Conduct trial with additional safety arm of 1800 subjects: CDSCO Panel Tells Bharath Biotech on Cholera Vaccine
Share